Technical Analysis for OLMA - Olema Pharmaceuticals, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 38.41 | 1.99% | 0.75 |
OLMA closed up 3.43 percent on Friday, March 5, 2021, on 1.98 times normal volume. The bears made the stock sink to a new 52-week low. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | N/A | Down | Down |
Historical OLMA trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Hammer Candlestick | Bullish | 1.99% | |
Stochastic Buy Signal | Bullish | 1.99% | |
Lizard Bullish | Bullish Day Trade Setup | 1.99% | |
Lower Bollinger Band Walk | Weakness | 1.99% | |
New 52 Week Low | Weakness | 1.99% | |
Wide Bands | Range Expansion | 1.99% | |
Lower Bollinger Band Touch | Weakness | 1.99% | |
Oversold Stochastic | Weakness | 1.99% | |
New 52 Week Closing Low | Bearish | 5.49% | |
New 52 Week Low | Weakness | 5.49% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
Lizard Bullish Entry | 32 minutes ago | |
Hammer Candlestick Entry | 32 minutes ago | |
Rose Above Previous Day's High | 32 minutes ago | |
Up 3% | 32 minutes ago | |
Up 2% | 32 minutes ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Olema Oncology is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers. Olema’s lead product candidate, OP-1250, is an orally available small molecule with combined activity as both a complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD). It is currently being evaluated as a single agent in an ongoing Phase 1/2 clinical trial in patients with recurrent, locally advanced or metastatic ER-positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer. Olema is headquartered in San Francisco.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Breast Cancer Treatment Of Breast Cancer Hormones Targeted Therapy Epidermal Growth Factor Receptor Her2 Her2/Neu Estrogen Antiestrogens Estrogen Receptor Selective Estrogen Receptor Degraders Fulvestrant
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Breast Cancer Treatment Of Breast Cancer Hormones Targeted Therapy Epidermal Growth Factor Receptor Her2 Her2/Neu Estrogen Antiestrogens Estrogen Receptor Selective Estrogen Receptor Degraders Fulvestrant
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 60.27 |
52 Week Low | 32.115 |
Average Volume | 91,804 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 44.97 |
20-Day Moving Average | 45.69 |
10-Day Moving Average | 41.17 |
Average True Range | 3.76 |
ADX | 20.54 |
+DI | 14.64 |
-DI | 31.63 |
Chandelier Exit (Long, 3 ATRs ) | 43.46 |
Chandelier Exit (Short, 3 ATRs ) | 43.39 |
Upper Bollinger Band | 56.81 |
Lower Bollinger Band | 34.58 |
Percent B (%b) | 0.14 |
BandWidth | 48.66 |
MACD Line | -2.21 |
MACD Signal Line | -0.91 |
MACD Histogram | -1.3017 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 47.27 | ||||
Resistance 3 (R3) | 46.49 | 42.50 | 45.67 | ||
Resistance 2 (R2) | 42.50 | 40.06 | 42.89 | 45.13 | |
Resistance 1 (R1) | 40.08 | 38.55 | 41.29 | 40.86 | 44.60 |
Pivot Point | 36.10 | 36.10 | 36.70 | 36.49 | 36.10 |
Support 1 (S1) | 33.68 | 33.65 | 34.89 | 34.46 | 30.72 |
Support 2 (S2) | 29.69 | 32.14 | 30.08 | 30.19 | |
Support 3 (S3) | 27.27 | 29.69 | 29.65 | ||
Support 4 (S4) | 28.05 |